Skip to main content
Fig. 7 | Journal of Experimental & Clinical Cancer Research

Fig. 7

From: Chemotherapy-induced CDA expression renders resistant non-small cell lung cancer cells sensitive to 5′-deoxy-5-fluorocytidine (5′-DFCR)

Fig. 7

EMT phenotype plasticity of H358 cells treated with different regimens. Left panel: Flow cytometry analysis of H358 cells on recovery day 11 (RD11) and recovery day 26 (RD26) after Schedule(3), Schedule + 5′-DFCR (4), and Schedule + 5′-DFCR RD2(5) treatment. EpCAM and Vimentin were used as EMT markers to distinguish different states of EMT. Cells were featured with epithelial (EpCAM+/Vimentin−), mesenchymal (EpCAM−/Vimentin+), hybrid (EpCAM+/Vimentin+), and negative (EpCAM−/Vimentin−). Righ panel: EMT phenotype at different timepoints after treatment with different regimens. Data are represented as mean ± SD (N = 2)

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us